We observed that, except for naïve CD4+ T cells that were reduced in BC patients, there were no differences between HDs and BC patients in the frequency of T cell subpopulations within CD4+ and CD8+ T cells (Supplementary Figure S3). This evidence concerns the gene CD4 and breast cancer.